These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25721678)

  • 21. Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.
    Eckert F; Alloussi S; Paulsen F; Bamberg M; Zips D; Spillner P; Gani C; Kramer U; Thorwarth D; Schilling D; Müller AC
    BMC Cancer; 2013 Jan; 13():27. PubMed ID: 23336502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy for prostate cancer: a single-center experience.
    Yoshida T; Nakayama M; Suzuki O; Matsuzaki K; Kobayashi Y; Takeda K; Arai Y; Kakimoto K; Nishiyama K; Nishimura K
    Jpn J Clin Oncol; 2011 Aug; 41(8):1031-6. PubMed ID: 21693484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed.
    Detti B; Bonomo P; Masi L; Doro R; Cipressi S; Iermano C; Bonucci I; Franceschini D; Di Brina L; Baki M; Simontacchi G; Meattini I; Carini M; Serni S; Nicita G; Livi L
    World J Urol; 2016 Mar; 34(3):311-7. PubMed ID: 26062525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.
    Narayan V; Vapiwala N; Mick R; Subramanian P; Christodouleas JP; Bekelman JE; Deville C; Rajendran R; Haas NB
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):355-361. PubMed ID: 27986349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
    Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
    Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of post-prostatectomy radiotherapy in one institution.
    Borg M; Sutherland P; Stapleton A; Bolt J; Steele D; Landers B; Porter A; Buxton S; Heilbornn C; Wong HZ
    Australas Radiol; 2006 Oct; 50(5):475-80. PubMed ID: 16981946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.
    Song W; Jeon HG; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Int J Urol; 2016 Jan; 23(1):56-61. PubMed ID: 26502086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer.
    Pinkawa M; Schubert C; Escobar-Corral N; Holy R; Eble MJ
    Strahlenther Onkol; 2015 Apr; 191(4):375-9. PubMed ID: 25339311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of recurrent disease after radical prostatectomy in 2007.
    Schwarz R; Graefen M; Krüll A
    World J Urol; 2007 Apr; 25(2):161-7. PubMed ID: 17333202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying appropriate patients for early salvage radiotherapy after prostatectomy.
    Karlin JD; Koontz BF; Freedland SJ; Moul JW; Grob BM; Wan W; Hagan MP; Anscher MS; Moghanaki D
    J Urol; 2013 Oct; 190(4):1410-5. PubMed ID: 23648223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up and risk of cancer death after radiation for post-prostatectomy rising prostate-specific antigen.
    Swanson GP; Du F; Michalek JE; Hermans M
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):62-8. PubMed ID: 20646861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up.
    Medini E; Medini I; Reddy PK; Levitt SH
    Cancer; 1996 Sep; 78(6):1254-9. PubMed ID: 8826948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
    Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
    Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.